- FENZA offers :-
- Broad Spectrum activity.
- Low rate of relapse.
- Patient compliant short course therapy.
- With Fenza, 84% patients were disease free from Vulvovaginal Candidiasis.
- Fenza offers 99% kill rate within 10 -17 hrs.
- Fenza has lower incidences of relapse rate.
- Patient compliant therapy of 1st day & 3rd day.
- Low efficacy on vaginal flora compared to dindamycin.